Anti-SIM20/ SMIM20/ C4orf52 functional antibody

Anti-SIM20/ SMIM20/ C4orf52 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SMIM20/SMIM20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0476-Ab-1/ GM-Tg-hg-SE0476-Ab-2Anti-Human SMIM20 monoclonal antibodyHuman
GM-Tg-rg-SE0476-Ab-1/ GM-Tg-rg-SE0476-Ab-2Anti-Rat SMIM20 monoclonal antibodyRat
GM-Tg-mg-SE0476-Ab-1/ GM-Tg-mg-SE0476-Ab-2Anti-Mouse SMIM20 monoclonal antibodyMouse
GM-Tg-cynog-SE0476-Ab-1/ GM-Tg-cynog-SE0476-Ab-2Anti-Cynomolgus/ Rhesus macaque SMIM20 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0476-Ab-1/ GM-Tg-felg-SE0476-Ab-2Anti-Feline SMIM20 monoclonal antibodyFeline
GM-Tg-cang-SE0476-Ab-1/ GM-Tg-cang-SE0476-Ab-2Anti-Canine SMIM20 monoclonal antibodyCanine
GM-Tg-bovg-SE0476-Ab-1/ GM-Tg-bovg-SE0476-Ab-2Anti-Bovine SMIM20 monoclonal antibodyBovine
GM-Tg-equg-SE0476-Ab-1/ GM-Tg-equg-SE0476-Ab-2Anti-Equine SMIM20 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0476-Ab-1/ GM-Tg-hg-SE0476-Ab-2; GM-Tg-rg-SE0476-Ab-1/ GM-Tg-rg-SE0476-Ab-2;
GM-Tg-mg-SE0476-Ab-1/ GM-Tg-mg-SE0476-Ab-2; GM-Tg-cynog-SE0476-Ab-1/ GM-Tg-cynog-SE0476-Ab-2;
GM-Tg-felg-SE0476-Ab-1/ GM-Tg-felg-SE0476-Ab-2; GM-Tg-cang-SE0476-Ab-1/ GM-Tg-cang-SE0476-Ab-2;
GM-Tg-bovg-SE0476-Ab-1/ GM-Tg-bovg-SE0476-Ab-2; GM-Tg-equg-SE0476-Ab-1/ GM-Tg-equg-SE0476-Ab-2
Products NameAnti-SMIM20 monoclonal antibody
Formatmab
Target NameSMIM20
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SMIM20 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0476-Ag-1Recombinant multi-species SIM20/ SMIM20/ C4orf52 protein


    Target information

    Target IDGM-SE0476
    Target NameSMIM20
    Gene ID389203,66278,501923,695372,611690,109499232,615093,100629401
    Gene Symbol and Synonyms1110067B18Rik,1810013D10Rik,C3H4orf52,C4orf52,C6H4orf52,MITRAC7,PNX,RGD1565192,SMIM20
    Uniprot AccessionQ8N5G0,C0HLM6,F1MDB2
    Uniprot Entry NameSIM20_HUMAN,SIM20_RAT,SIM20_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000250317
    Target ClassificationN/A

    The target: SMIM20, gene name: SMIM20, also named as C4orf52, MITRAC7, PNX. Involved in mitochondrial cytochrome c oxidase assembly. Located in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.